Starting Ultomiris (ravulizumab-cwvz)Your first 90 days with generalized myasthenia gravis: the steps, the dates and who to call
Trial Friendtrialfriend.com
How you take it
An infusion into a vein from a healthcare provider. You get a starting dose, a second dose 2 weeks later, then one every 8 weeks. The dose depends on how much you weigh.
Before your first dose
- A blood test that shows AChR antibodies, because Ultomiris is approved for myasthenia gravis only in adults who have them.
- Meningitis shots, the ACWY shot and the MenB shot, at least 2 weeks before your first infusion. Your doctor checks whether older shots still count.
- If you cannot wait 2 weeks, the label says you get antibiotics and the shots as soon as possible.
- Tell your doctor if you have a fever or an infection. The label says Ultomiris is not started during a serious meningococcal infection that has not cleared.
- Tell your neurologist about plasma exchange, IVIG or a medicine such as efgartigimod, because the label says these affect Ultomiris.
- Ask your neurologist whether you also need a pneumonia shot or a Hib shot.
- Keep your Patient Safety Card with you during treatment and for 8 months after your last dose.
- Sign up with Alexion OneSource, the drugmaker's support program, for help with insurance and costs. With private insurance, you may pay as little as $0.
- After your insurance approves, a clinic or infusion service in the safety program books your first visit.
The first 90 days
- 4 weeks beforeOneSource enrollment and the insurance check
- 3 weeks beforeVaccines done, or scheduled
- 2 weeks beforeMeningitis shots done, at least 2 weeks before your first infusion
- Week beforeApproval, then booking a certified site
- Day 1Day 1: first infusion, then at least 1 hour of watching
- Day 15Day 15: second infusion, 2 weeks after the first
- Day 71, then every 56 daysOne infusion every 8 weeks from here
- After plasma exchange or IVIGAn extra dose within 4 hours
- Day 90Three months in
Trial Friend, trialfriend.com. From the Ultomiris FDA label dated October 29, 2026 and the drugmaker's program, checked November 13, 2026. Not medical advice: Trial Friend is not a medical provider, and your doctor decides your dose and tests.